Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Bone marrow stromal cell antigen 1 (BST1) is a glycosylated membrane ectoenzyme encoded by the BST1 gene, belonging to ADP-ribosyl cyclase enzyme family and acting as a core regulator of bone marrow stromal niche signaling and hematopoietic immune cell maturation. BST1 is predominantly expressed in bone marrow stromal fibroblasts, hematopoietic progenitor populations and mature immune cells, with evolutionarily conserved extracellular catalytic cyclase domains across species, serving as an essential modulator for cyclic ADP-ribose generation, intracellular calcium mobilization and stromal niche cytokine secretion. BST1-mediated enzymatic activity exerts decisive effects on sustaining balanced hematopoietic progenitor proliferation, supporting stepwise immune cell differentiation and maintaining intact bone marrow microenvironment stability under physiological conditions. Furthermore, BST1 coordinates downstream signaling cascades governing stromal cell cross-talk, progenitor survival and tissue immune cell trafficking to safeguard steady hematopoietic tissue function. Distinct from other cyclase enzymes with divergent tissue expression patterns, BST1 carries unique non-redundant duties in bone marrow niche signal transduction, rendering it indispensable for regular hematopoietic development, stromal-immune cell communication and overall bone marrow tissue homeostasis.
BST1 executes biological functions through extracellular catalytic conversion of NAD substrates to generate cyclic ADP-ribose signaling molecules, which modulate calcium-dependent transcriptional programs governing progenitor cell survival and differentiation within the bone marrow niche, forming a supportive signaling network for hematopoietic lineage maturation. Its conserved catalytic ectodomains mediate substrate recognition and cyclic nucleotide synthesis, enabling precise tuning of stromal niche signaling intensity and immune progenitor developmental signal transmission. BST1-dependent signaling sustains systemic hematopoietic equilibrium, covering intact cyclic nucleotide signaling cycles, coordinated stromal-hematopoietic cell interaction and persistent progenitor pool maintenance. BST1 participates in an extensive spectrum of biological processes, such as ADP-ribosyl cyclase catalytic metabolism, bone marrow stromal niche regulation, hematopoietic immune cell differentiation and progenitor cell survival control. Suppressed or dysfunctional BST1 severely disrupts stromal niche supportive signaling, disturbs immune progenitor maturation balance and elevates susceptibility to hematopoietic developmental defects and bone marrow inflammatory lesions. Therefore, BST1 constitutes a pivotal research target for investigating stromal niche biology, hematopoietic developmental physiology and bone marrow disorder pathogenic mechanisms.
Fig. 1 Membrane CD157 (BST1) interacts with integrins to activate ERK and AKT pathways. AKT inhibits GSK-3β to stabilize Mcl-1 and block mitochondrial apoptosis, while triggering mTORC1 cascade to maintain cell survival. Mcl-1 inhibitor counteracts CD157-mediated anti-apoptotic effects.1
The biological functions of BST1 are focused on extracellular ADP-ribosyl cyclase catalysis, cyclic nucleotide signal generation and hematopoietic progenitor regulation:
Creative Biolabs offers high-quality BST1 proteins via optimized expression systems, covering full-length BST1 and isolated catalytic cyclase domain variants. These products retain native spatial conformation and intrinsic ADP-ribosyl cyclase biological activity, suitable for ectoenzyme catalytic activity analysis, stromal cell interaction studies and small molecule compound screening targeting hematopoietic developmental disorders. All BST1 proteins undergo rigorous quality control to guarantee consistent functional performance and reliable application across diverse research platforms.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom engineered BST1 stable cell lines, including overexpression and gene silencing models. These cell line models are optimized for bone marrow niche research, hematopoietic progenitor differentiation observation and stromal regulatory compound response profiling. Each cell line undergoes strict validation procedures to ensure steady target expression levels and uniform functional performance across multiple experimental scenarios.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting BST1 are developed with advanced antibody engineering workflows, without cross-reactivity against other ADP-ribosyl cyclase family homologs. These antibodies receive multi-scenario functional validation, applicable to protein expression profiling, stromal cell membrane localization detection, enzyme-substrate binding interaction assessment and hematopoietic niche research, enabling precise characterization of BST1 expression patterns, subcellular compartment distribution and functional modulation under physiological and pathological states.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for BST1 research: